BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3881347)

  • 21. Evidence that the major surface proteins of three Leishmania species are structurally related.
    Etges RJ; Bouvier J; Hoffman R; Bordier C
    Mol Biochem Parasitol; 1985 Feb; 14(2):141-9. PubMed ID: 3990704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Killing of Leishmania tropica amastigotes by factors in normal human serum.
    Hoover DL; Berger M; Nacy CA; Hockmeyer WT; Meltzer MS
    J Immunol; 1984 Feb; 132(2):893-7. PubMed ID: 6690622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stage-specific glycosphingolipids from amastigote forms of Leishmania (L.) amazonensis. Immunogenicity and role in parasite binding and invasion of macrophages.
    Straus AH; Levery SB; Jasiulionis MG; Salyan ME; Steele SJ; Travassos LR; Hakomori S; Takahashi HK
    J Biol Chem; 1993 Jun; 268(18):13723-30. PubMed ID: 8514804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani.
    Saar Y; Ransford A; Waldman E; Mazareb S; Amin-Spector S; Plumblee J; Turco SJ; Zilberstein D
    Mol Biochem Parasitol; 1998 Sep; 95(1):9-20. PubMed ID: 9763285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of membrane-enriched and high molecular weight proteins in Leishmania infantum promastigotes and axenic amastigotes.
    Brotherton MC; Racine G; Ouameur AA; Leprohon P; Papadopoulou B; Ouellette M
    J Proteome Res; 2012 Aug; 11(8):3974-85. PubMed ID: 22716046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenic differences between axenic amastigotes & promastigotes of Leishmania donovani.
    Chattopadhayay R; Kaur S; Ganguly NK; Mahajan RC
    Indian J Med Res; 1996 Dec; 104():349-54. PubMed ID: 8996935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Leishmania (Leishmania) amazonensis amastigote glycosphingolipids in macrophage infectivity.
    Tanaka AK; Gorin PA; Takahashi HK; Straus AH
    Braz J Med Biol Res; 2007 Jun; 40(6):799-806. PubMed ID: 17581678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uptake of Z-Tyr[125I]-AlaCHN2, an irreversible cysteine proteinase inhibitor, by lesion amastigotes, axenic amastigotes and promastigotes of Leishmania mexicana.
    Pral EM; Alfieri SC
    Braz J Med Biol Res; 1996 Aug; 29(8):987-94. PubMed ID: 9181079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Leishmania promastigote surface antigen 2 complex is differentially expressed during the parasite life cycle.
    Handman E; Osborn AH; Symons F; van Driel R; Cappai R
    Mol Biochem Parasitol; 1995 Nov; 74(2):189-200. PubMed ID: 8719160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leishmania major: differential regulation of the surface metalloprotease in amastigote and promastigote stages.
    Schneider P; Rosat JP; Bouvier J; Louis J; Bordier C
    Exp Parasitol; 1992 Sep; 75(2):196-206. PubMed ID: 1516667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An assay to quantitate the binding of Leishmania amastigotes to macrophages.
    Mosser DM
    J Immunol Methods; 1990 Jul; 130(2):235-42. PubMed ID: 2165100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leishmania mexicana pifanoi: in vivo and in vitro interactions between amastigotes and macrophages.
    Pan AA; Honigberg BM
    Z Parasitenkd; 1985; 71(1):3-13. PubMed ID: 3984450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amastigote stage-specific monoclonal antibodies against Leishmania major.
    Jaffe CL; Rachamim N
    Infect Immun; 1989 Dec; 57(12):3770-7. PubMed ID: 2680982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The heterogeneity of Leishmania cell-surface antigens.
    Hernández AG; Payares G; Misle A; Dagger F
    Parasitol Res; 1989; 75(8):583-8. PubMed ID: 2771925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species-specific antibodies to Leishmania tropica (minor) recognize somatic antigens and exometabolites.
    Jaffe CL; Sarfstein R
    J Immunol; 1987 Aug; 139(4):1310-9. PubMed ID: 3302043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axenic amastigote cultivation and in vitro development of Leishmania orientalis.
    Chanmol W; Jariyapan N; Somboon P; Bates MD; Bates PA
    Parasitol Res; 2019 Jun; 118(6):1885-1897. PubMed ID: 30972571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymoquinone Effect on Leishmania tropica/infantum and Leishmania-Infected Macrophages.
    KarimiPourSaryazdi A; Jafari MM; Pirestani M; Sadeghi SH; Moghadamizad Z
    Acta Parasitol; 2023 Dec; 68(4):735-745. PubMed ID: 37589882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies specific for Leishmania tropica. I. Characterization of antigens associated with stage- and species-specific determinants.
    Jaffe CL; McMahon-Pratt D
    J Immunol; 1983 Oct; 131(4):1987-93. PubMed ID: 6194223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential role and apoptotic profile of three medicinal plant extracts on
    Ilaghi M; Sharifi I; Sharififar F; Sharifi F; Oliaee RT; Babaei Z; Meimamandi MS; Keyhani A; Bamorovat M
    Parasite Epidemiol Control; 2021 Feb; 12():e00201. PubMed ID: 33511293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages.
    Channon JY; Roberts MB; Blackwell JM
    Immunology; 1984 Oct; 53(2):345-55. PubMed ID: 6490087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.